• Search
  • Helpdesk
  • Sales contact

fundraising

Expanding investor confidence: The strategic value of Patient Reported Outcomes (PROs) in biotech fundraising

For biotech companies engaged in the clinical development of a therapeutic innovation, securing investor trust is as critical as demonstrating the scientific value of their molecule. One powerful yet underleveraged...
Follow us on social media
Subscribe to our newsletter
About the author